![]() |
Market Research Report
Product code
1064779
Global Narcotic analgesics Market 2021-2027 |
Global Narcotic analgesics Market 2021-2027 |
Published: February 1, 2022
Orion Market Research Pvt Ltd
Content info: 100 Pages
Delivery time: 2-3 business days
|
Global Narcotic analgesics Market Size, Share & Trends Analysis Report by Type (Morphine, Fentanyl, and Tramadol) by Application (Hospital, Medical Centre, Others) and Forecast (2020-2026)
The global narcotic analgesics market is anticipated to grow at a considerable CAGR during the forecast period. The global narcotic analgesic medicines market is being driven by an increase in the prevalence of osteoarthritis, back pain, and rheumatoid arthritis. The market for narcotic analgesic medicines is also being driven by an increase in the occurrence of overactive bladder. The market for narcotic analgesic medicines is expected to grow due to an increase in the geriatric population suffering from osteoarthritis pain and the availability of a wide range of over-the-counter pain relievers.
The global narcotic analgesics market is segmented based on type and application. Based on type, the narcotic analgesics market is segmented into morphine, fentanyl, and tramadol. Based on application, the narcotic analgesics market is segmented into hospital, medical center, and others.
Geographically, the global narcotic analgesics market covers the analysis of four major regions including North America (the US and Canada), Europe (UK, Germany, Italy, Spain, France, and Rest of Europe), Asia-Pacific (China, Japan, India, and Rest of Asia-Pacific), and the Rest of the World. Some of the companies operating in the global narcotic analgesics market include Sanofi S.A., Endo Pharmaceuticals., GlaxoSmithKline PLC., Pfizer., Reckitt Benckiser., and Novartis AG., among others.
Market Segmentation
The Report Covers